Jonathan Dosik, MD
Dermatology · Glen Rock, NJNPI 1396704755
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $777 of the $1,076 with a category attached, or 72.2%. 14 manufacturers reported payments, led by Johnson & Johnson at 58.5% of the total. 2025 is the largest year on record at $473, more than ten times the $14 reported in 2019. That places this record below the midpoint for dermatology clinicians in NJ, where the typical reported total is $1,986.
Across 53 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$629
- Pfizer$130
- Galderma Laboratories, L.p.$64
- Novartis$41
- Regeneron Healthcare Solutions, Inc.$40
- Sanofi$29
- plus $143 from 8 others
Across 183 payments — averaging $46,025 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Noven Pharmaceuticals, Inc.$3.3M
- Sanofi US Services Inc.$3.2M
- Boehringer Ingelheim International GmbH$1.3M
- Next Science LLC$315K
- Arcutis Biotherapeutics, Inc.$167K
- Medline Industries LP$59K
- plus $70K from 5 others
What the payments were for
- Food & beverage$77772%
- Education$29928%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 29 | $629 |
| Pfizer | 5 | $130 |
| Galderma Laboratories, L.p. | 4 | $64 |
| Novartis | 3 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Sanofi | 2 | $29 |
| Almirall LLC | 1 | $21 |
| Sensus Healthcare, Inc. | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Blueprint Medicines Corporation | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Strata Skin Sciences, Inc. | 1 | $14 |
How this compares
$1,076 in reported general payments places this provider in the 35th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 37 | $148,264 |
| Clobetasol Propionate | 192 | $5,199 |
| Fluorouracil | 41 | $2,502 |
| ValacyclovirValacyclovir Hcl | 59 | $1,904 |
| Triamcinolone Acetonide | 141 | $1,855 |
| Doxycycline Hyclate | 47 | $1,377 |
| Metronidazole | 40 | $1,369 |
| Mometasone Furoate | 70 | $1,149 |
| Fluocinonide | 31 | $923 |
| Clotrimazole | 17 | $903 |
| Ketoconazole | 55 | $875 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 54 | $676 |
| Dapsone | 11 | $587 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 24 | $409 |
| Prednisone | 34 | $245 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Glen Rock
- Omar NoorSomerset$4.5M
- Linda Cappiello-LindsleyHoboken$2.3M
- Brian KeeganEast Windsor$1.7M
- Jerry BagelEast Windsor$1.6M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
- Brian MachlerFlorham Park$346K
- Jeanine DownieMontclair$327K
- Aanand GeriaRutherford$251K
- Jason MillerFreehold$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.